Insight into Atomic Resolution of the Cross-Seeding between Tau/Mutated Tau and Amyloid-β in Neurodegenerative Diseases

Yoav Atsmon-Raz, Yifat Miller

Research output: Contribution to journalReview articlepeer-review

4 Scopus citations

Abstract

Tau and amyloid-β (Aβ) are the primary components of amyloid plaques in neurodegenerative diseases, such as Alzheimer's disease (AD) and frontotemporal dementia with parkinsonism linked to chromosome 17 (FTDP-17). Cross-seeding between Aβ and tau, or Aβ and mutated tau, is a key phenomenon observed in these neurodegenerative diseases. This review addresses the importance of investigating Aβ tau and Aβ mutated tau oligomeric complexes at atomic resolution. It also provides an overview of both experimental and computational studies performed on cross-seeding between tau/mutated tau and Aβ, and addresses further directions for future studies. The cross-seeding phenomenon could contribute to explaining, at least in part, the still unknown origins of the pathological conditions and may assist in preventing aggregation in amyloidogenic diseases with drug design and other therapeutic approaches.

Original languageEnglish
Pages (from-to)628-636
Number of pages9
JournalIsrael Journal of Chemistry
Volume55
Issue number6
DOIs
StatePublished - 1 Jun 2015

Keywords

  • amyloid beta-peptides
  • drug delivery
  • molecular dynamics
  • neurochemistry
  • proteins

Fingerprint

Dive into the research topics of 'Insight into Atomic Resolution of the Cross-Seeding between Tau/Mutated Tau and Amyloid-β in Neurodegenerative Diseases'. Together they form a unique fingerprint.

Cite this